… under constant vaccination control, in this section we seek an optimal vaccination strategy
with the three available HPV vaccines, in order to effectively repress the HPV infection. We …

… HPV vaccine probably results in higher GMTs than control at … HPV vaccine, compared with
control or other HPV vaccines, … The duration of protection of HPV vaccines in people with …

… Two licensed HPV vaccines—the bivalent vaccine comprising HPV types 16 and 18, and …
We also discuss the methods used to verify the effectiveness of HPV vaccination. HPV …

… Potential conflicts of interest: RH is the co–principal investigator of the Costa Rica HPV
vaccine trial, which is sponsored and funded by the US National Cancer Institute (NCI; contract …

… new vaccine … HPV-related cancers was superior to Gardasil for both males and females.
And yet, with no cited preferences for one vaccine or the other, it is certain that HPV vaccinations …

… Because the time from vaccination to cancer development can … the vaccine was introduced,
reductions in HPV vaccine type … show promising results for the relatively new HPV vaccine. …

… the nonavalent HPV vaccine, abbreviated as 9vHPV in the rest of this paper (controlled with
… the immunogenicity of 9vHPV vaccine with respect to 4vHPV is non-inferior and that 9vHPV …

… was assessed extensively in randomised controlled clinical trials conducted prior to … regarding
the safety of HPV vaccines. In summary, both vaccines are associated with relatively high …

… the provision of cancer control services through a … HPV-related cervical cancers as well as
other HPV-related diseases. However, to complete the picture of HPV vaccines for all cancers…

… [1, 2], which has led to the design of prophylactic vaccines. … HPV types [3], it is accepted
that effective HPV vaccines should contain the types responsible for most cervical cancers [4]. It …